EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized study evaluating the efficacy and impact on function of two different
doses of nab-Paclitaxel in elderly patients with advanced breast cancer.